BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 24088401)

  • 1. Differences in brain metabolism associated with agitation and depression in Alzheimer's disease.
    Tsai CF; Hung CW; Lirng JF; Wang SJ; Fuh JL
    East Asian Arch Psychiatry; 2013 Sep; 23(3):86-90. PubMed ID: 24088401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.
    Shinno H; Inagaki T; Miyaoka T; Okazaki S; Kawamukai T; Utani E; Inami Y; Horiguchi J
    J Neurol Sci; 2007 Sep; 260(1-2):132-8. PubMed ID: 17540407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite investigation in both anterior and posterior cingulate gyri in Alzheimer's disease spectrum using 3-tesla MR spectroscopy.
    Lim TS; Hong YH; Lee HY; Choi JY; Kim HS; Moon SY
    Dement Geriatr Cogn Disord; 2012; 33(2-3):149-55. PubMed ID: 22722669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
    Wang Z; Zhao C; Yu L; Zhou W; Li K
    Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
    Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance spectroscopy performance for detection of dementia, Alzheimer's disease and mild cognitive impairment in a community-based survey.
    García Santos JM; Gavrila D; Antúnez C; Tormo MJ; Salmerón D; Carles R; Jiménez Veiga J; Parrilla G; Torres del Río S; Fortuna L; Navarro C
    Dement Geriatr Cogn Disord; 2008; 26(1):15-25. PubMed ID: 18566544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydrogen proton MR spectroscopy of posterior portion cingulate gyrus of patients with Alzheimer's disease: a case control study].
    Wang T; Xiao SF; Li X; Wang Y; Ding B; Ling HW; Chen KM
    Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(1):37-40. PubMed ID: 19489242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced N-acetylaspartate to creatine ratio in the posterior cingulate correlates with cognition in Alzheimer's disease following four months of rivastigmine treatment.
    Penner J; Wells JL; Borrie MJ; Woolmore-Goodwin SM; Bartha R
    Dement Geriatr Cogn Disord; 2015; 39(1-2):68-80. PubMed ID: 25358336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of findings in advanced MR techniques with global severity scales in patients with some grade of cognitive impairment.
    Fayed N; Dávila J; Oliveros A; Medrano J; Castillo J
    Neurol Res; 2010 Mar; 32(2):157-65. PubMed ID: 20158954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurometabolic characteristics in the anterior cingulate gyrus of Alzheimer's disease patients with depression: a (1)H magnetic resonance spectroscopy study.
    Guo Z; Zhang J; Liu X; Hou H; Cao Y; Wei F; Li J; Chen X; Shen Y; Chen W
    BMC Psychiatry; 2015 Dec; 15():306. PubMed ID: 26626864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cortical brain metabolism as measured by proton spectroscopy is related to memory performance in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Rami L; Gómez-Ansón B; Bosch B; Sánchez-Valle R; Monte GC; Villar A; Molinuevo JL
    Dement Geriatr Cogn Disord; 2007; 24(4):274-9. PubMed ID: 17717413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (1)H-MRS asymmetry changes in the anterior and posterior cingulate gyrus in patients with mild cognitive impairment and mild Alzheimer's disease.
    Guo Z; Liu X; Hou H; Wei F; Chen X; Shen Y; Chen W
    Compr Psychiatry; 2016 Aug; 69():179-85. PubMed ID: 27423359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
    Waragai M; Moriya M; Nojo T
    J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional investigation of bilateral posterior cingulate gyri using multivoxel MR spectroscopy.
    Lim TS; Hong YH; Choi JY; Kim HS; Moon SY
    Eur Neurol; 2012; 67(5):279-86. PubMed ID: 22472573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between cognitive impairment and in vivo metabolite ratios in patients with clinical Alzheimer's disease and vascular dementia: a proton magnetic resonance spectroscopy study.
    Waldman AD; Rai GS
    Neuroradiology; 2003 Aug; 45(8):507-12. PubMed ID: 12879326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
    Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
    NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical neurochemistry in euthymic patients with bipolar I disorder.
    Scherk H; Backens M; Schneider-Axmann T; Usher J; Kemmer C; Reith W; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4):285-94. PubMed ID: 19921970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.